Christopher Gromisch
Pre-Doctoral Trainee
Boston University School of Medicine, Graduate Medical Sciences
Dept of Biochemistry

Development of a novel Antibody Drug Conjugate for the treatment of pancreatic cancer
09/01/2018 - 08/31/2021 (PI)
NIH/National Cancer Institute


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Gromisch CM, Tan GLA, Pasion KA, Moran AM, Gromisch MS, Grinstaff MW, Carr FJ, Herrera VLM, Ruiz-Opazo N. Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu/nu model. BMC Cancer. 2021 Apr 14; 21(1):407.View Related Profiles. PMID: 33853558; PMCID: PMC8048286; DOI: 10.1186/s12885-021-08107-w;
  2. Gromisch C, Qadan M, Machado MA, Liu K, Colson Y, Grinstaff MW. Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease. Cancer Res. 2020 08 15; 80(16):3179-3192.View Related Profiles. PMID: 32220831; PMCID: PMC7755309; DOI: 10.1158/0008-5472.CAN-19-2731;
  3. Wong CK, Gromisch C, Ozturk S, Papageorgis P, Abdolmaleky HM, Reinhard BM, Thiagalingam A, Thiagalingam S. MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer. Cancer Biol Ther. 2019; 20(8):1113-1120.View Related Profiles. PMID: 30922194; PMCID: PMC6605987; DOI: 10.1080/15384047.2019.1595285;

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 3 publications over 3 distinct years, with a maximum of 1 publications in 2019 and 2020 and 2021


Contact for Mentoring:

700 Albany St Ctr for Adv Biomed Res
Boston MA 02118
Google Map

Gromisch's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department